financetom
Business
financetom
/
Business
/
Update: Market Chatter: Micron Plans China Server Chips Business Exit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Micron Plans China Server Chips Business Exit
Oct 20, 2025 1:57 AM

04:44 AM EDT, 10/20/2025 (MT Newswires) -- (Updates with Micron's response in the third paragraph and the latest stock price movement in the fourth paragraph.)

Micron Technology ( MU ) intends to stop supplying server chips to Chinese data centers following the business' failure to recover from a 2023 government ban on its products in critical infrastructure in that market, Reuters reported Friday, citing two people briefed on the decision.

The company will continue to sell chips to laptop maker Lenovo and another Chinese customer, which both have notable data center operations outside of China, according to the report. Micron will also continue selling chips to companies in the automobile and cell phone sectors in that market, Reuters reported, citing one of the sources.

The Cyberspace Administration of China's 2023 decision has "impacted" Micron's data center business in that market, the company said. "Micron values its customers in China, and we continue to provide our portfolio of industry-leading DRAM and NAND products to our customers, while respecting and abiding by applicable laws and regulations everywhere we do business."

Micron shares were up 3% in recent premarket activity Monday.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Acadia to stop trials of antipsychotic drug after it fails schizophrenia study
Mar 11, 2024
March 11 (Reuters) - Acadia Pharmaceuticals ( ACAD ) said on Monday it does not plan to conduct further clinical trials of its antipsychotic drug, pimavanserin, after it failed to improve negative symptoms of schizophrenia in a late-stage study. Shares of the California-based company fell 16% in extended trading. The decision comes after two failed attempts to secure regulatory approval...
Walgreens settles New York charges it inflated prices of infant formula
Walgreens settles New York charges it inflated prices of infant formula
Mar 11, 2024
NEW YORK (Reuters) - Walgreens has settled charges by New York Attorney General Letitia James that the pharmacy chain grossly inflated prices on at least 20 infant formula products in 2022 after a recall by Abbott Labs led to a nationwide shortage. Walgreens did not admit or deny wrongdoing in entering an assurance of discontinuance dated March 7 and made...
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
BRIEF-Assure Holdings Enters Into Agreement To Sell Certain Of Its Assets To MPOWERHealth
Mar 11, 2024
March 11 (Reuters) - Assure Holdings Corp ( IONM ): * ASSURE HOLDINGS ENTERS INTO AGREEMENT TO SELL CERTAIN OF ITS ASSETS TO MPOWERHEALTH * ASSURE HOLDINGS CORP ( IONM ): TO SELL CERTAIN ASSETS OF ITS IONM BUSINESS TO MPOWERHEALTH FOR UP TO $4.5 MILLION Source text for Eikon: Further company coverage: ...
BRIEF-Arogo Capital Acquisition Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
BRIEF-Arogo Capital Acquisition Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
Mar 11, 2024
March 11 (Reuters) - Arogo Capital Acquisition Corp ( AOGO ) : * AROGO CAPITAL ACQUISITION CORP. ( AOGO ) RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM MARKET VALUE DEFICIENCY Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved